期刊文献+

一株小鼠自发性乳腺癌细胞系MA-891的建立及其免疫生物学特征 被引量:1

MA891──An Established Spontaneous Mouse Mammary Adenocarcinoma Cell Line and Its Immunologic Characteristics
下载PDF
导出
摘要 从津白Ⅱ号小鼠自发性乳腺癌TA2MA891建立了体外长期传代细胞系MA891。MA891细胞保持了TA2MA891的高转移特性,皮下接种后肿瘤进行生长,并无一例外地发生肿瘤肺转移。MA891细胞的免疫原性极弱,表现为:(1)淋巴细胞-肿瘤细胞混合培养(MLTC)只能诱导出低水平的细胞毒T细胞(CTL);(2)肿瘤浸润淋巴细胞(TIL)含量少,体外经IL-2扩增后只表现出微弱的细胞毒活性;(3)在小鼠体内不能诱导特异性肿瘤排斥反应。MA891可作为研究人类肿瘤生物治疗的有用实验模型。 Objective To characterize the immunologic properties of an established mouse mammary tumor cell line MA891. Methods From a spontaneous mouse mammary adenocarclonma(TA2 MA891) of TA2 mouse origin, an in vitro passaged cell line MA891 was maintained in RPMI164o with 10% new born calf serum. The immunogenecity of MA891 was studied by classical tumor transplantation rejection assay, generation of cytotoxic T lymphocytes(CTL) by syngeneic secondary mixed lymphocyte-tumor cell culture(MLTC) and cytotoxic assayof tumor infiltrating lymphocytes(TIL). Results MA891 maintained the high metastatic potential of the parental TA2 MA891 tumor passaged in vivo. Transplantation rejection studies indicated that amputation of a hind limb with growing tumor in the footpad did not protect the mice from a second subcutaneous challenge of the same tumor. The cytotoxic activities of both CTL and TIL were shownto be very weak.Conclusion MA891 is a mouse tumor of very low immunogenecity. It can be used as a mouse tumor model for studying cancer metastasis in humans.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 1997年第4期273-277,共5页 Acta Academiae Medicinae Sinicae
关键词 乳腺癌 细胞系 肿瘤转移 免疫原性 MA-891 mouse mammary adenocarcinoma tumor metastasis tumor immunogenecity
  • 相关文献

参考文献6

  • 1罗利群,中国免疫学杂志,1995年,11卷,294页
  • 2高朋根,中国医学科学院学报,1994年,16卷,148页
  • 3罗利群,中华肿瘤杂志,1994年,16卷,231页
  • 4Chen L,Immunol Today,1993年,14卷,483页
  • 5刘向阳,中国免疫学杂志,1993年,9卷,增刊,91页
  • 6石卫,中国免疫学杂志,1986年,2卷,14页

同被引文献13

  • 12002年上海市市区恶性肿瘤发病率[J].肿瘤,2006,26(5):496-496. 被引量:17
  • 2杨骅,王仙平,郁琳琳,郑树.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志,1996,18(3):169-172. 被引量:229
  • 3陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1996.33-34.
  • 4Price JE,Polyzos A,Zhang RD,et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice [J].Cancer Res,1990,50(3) :717-721.
  • 5Masaharu T,Hiroyasu I, Miyako B,et al.Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in wistar rats [J].Int J Cancer, 1999, 80 (3) :396-399.
  • 6Boehm-Viswanathan T.Is angiogenesis inhibition the Holy Grail of cancer therapy? [J].Curr Opin Oncol, 2000,12 (1) : 89-94.
  • 7Hanahan D, Folkman J.Pattems and emergine mechanisms of the angiogenic switch during tumorgenesis [J].Cell, 1996,86 (3) : 353-356.
  • 8Giatromanolaki A, Sivridis E, Brekken R, et al.The angiogenic "vascular endothelial growth factor/flk-1 (KDR) receptor" pathway in patients with endometrial carcinomal:prognostic and therapeutic implications[J].Cancer, 2001,92 (10) : 2569-2577.
  • 9Harold F.Vascular growth factor,microvascular hyperpenneability,and angiogenesis [J] .Am J Pathol, 1995,146(10) : 1029-1039.
  • 10Dvorak HF, Brown LF, Detmar M, et al.Vascular permeability factorvascular endothelial growth factor, microvascular hyperpermeability,and angiogenesis[J].Am J Pathol, 1995,146(5) : 1029-1039.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部